🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Sagimet Biosciences Inc.
Denifanstat
Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics called fatty acid synthase (FASN) inhibitors for diseases caused by dysfunctional lipid metabolism pathways. Its lead drug candidate, Denifanstat, targets nonalcoholic steatohepatitis and acne. The company is also working on FASN inhibitors for cancer treatment.
About | Contact | Careers | About | Directors | About | About | Contact | About | About | About | About | Contact | ESG | Events | About | Careers
Symbol: SGMT
Recent Price: $4.72
Industry: Biotechnology
CEO: Mr. David A. Happel
Sector: Healthcare
Employees: 8
Address: 155 Bovet Road, San Mateo, CA 94402
Phone: 650-561-8600
Leadership
- George Kemble, PhD, Executive Chairman of the Board
- David Happel, Chief Executive Officer
- Anne Phillips, MD,
- Beth Seidenberg, MD,
- Elizabeth Grammer, Esq,
- Jennifer Jarrett,
- Merdad Parsey, MD, PhD,
- Paul Hoelscher,
- Tim Walbert,
Last updated: 2024-12-31